Sunday, June 26, 2016

This blinded trial did not show a significant reduction of systolic blood pressure in patients with resistant hypertension 6 months after renal-artery denervation as compared with a sham control. (Funded by Medtronic; SYMPLICITY HTN-3 ClinicalTrials.gov number, NCT01418261.)

http://www.nejm.org/doi/full/10.1056/NEJMoa1402670#t=abstract
Post a Comment